M Monconduit

Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

N Smadja, C Fruchart, F Isnard et al. · Leukemia · 1998 · 169 citations

Life Sciences, Hematology, Oncology +17

Thalidomide in patients with advanced multiple myeloma: a study of 83 patients–report of the intergroupe francophone du myélome (IFM)

Ibrahim Yakoub‐Agha, Michel Attal, Charles Dumontet et al. · The Hematology Journal · 2002 · 83 citations

Medicine, Hematology, Oncology +14

Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology

J Goasguen, Marc Zandecki, Claire Mathiot et al. · Leukemia Research · 1999 · 53 citations

Medicine, Hematology, Oncology +14

77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’

E.M. Noordijk, Patrice Carde, Anton Hagenbeek et al. · International Journal of Radiation Oncology*Biology*Physics · 1997 · 50 citations

Medicine, Oncology, Radiation Oncology +15

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.

Philippe Moreau, D Fière, W. R. Bezwoda et al. · Journal of Clinical Oncology · 1997 · 43 citations

Medicine, Hematology, Pharmacology +17